Can thalidomide improve outcome in patients with multiple myeloma?

被引：0
|
作者：
Paul G Richardson
Constantine S Mitsiades
Nikhil C Munshi
Kenneth C Anderson
机构：
[1] the Clinical Director of the Jerome Lipper Multiple Myeloma Center (JLMMC) at the Dana-Farber Cancer Institute (DFCI),Instructor in Medicine at Harvard Medical School (HMS)
[2] the Department of Medical Oncology of DFCI and the Department of Medicine at Brigham and Women's Hospital,undefined
[3] the Associate Director of the JLMMC of DFCI,undefined
[4] Associate Professor of Medicine at HMS,undefined
[5] the Director of the JLMMC,undefined
[6] Chief of Division of Hematologic Neoplasia at DFCI and the Kraft Family Professor of Medicine at HMS,undefined
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：590 / 591
页数：1
相关论文
共 50 条
  • [1] Can thalidomide improve outcome in patients with multiple myeloma?
    Richardson, Paul G.
    Mitsiades, Constantine S.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (11): : 590 - 591
  • [2] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [3] Thalidomide in elderly patients with multiple myeloma
    Kusumi, Eiji
    Matsumura, Tomoko
    Yuji, Koichiro
    Tanaka, Yuji
    Kami, Masahiro
    LANCET, 2006, 367 (9527): : 1977 - 1977
  • [4] Immunoreactivity of thalidomide in patients with multiple myeloma.
    Luo, SK
    Li, J
    Hong, WD
    Zhou, ZH
    BLOOD, 2002, 100 (11) : 367B - 367B
  • [5] Thalidomide in patients with multiple myeloma and renal failure
    Fakhouri, F
    Guerraoui, H
    Presne, C
    Peltier, J
    Delarue, R
    Muret, P
    Knebelmann, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 96 - 97
  • [6] Thalidomide metabolites in mice and patients with multiple myeloma
    Lu, J
    Palmer, BD
    Kestell, P
    Browett, P
    Baguley, BC
    Muller, G
    Ching, LM
    CLINICAL CANCER RESEARCH, 2003, 9 (05) : 1680 - 1688
  • [7] Role of thalidomide in the treatment of patients with multiple myeloma
    Morgan, Gareth J.
    Davies, Faith E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 : S14 - S22
  • [8] Thalidomide for multiple myeloma
    Folkman, J
    Rogers, MS
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2389 - 2390
  • [9] Thalidomide in multiple myeloma
    Moehler, T. M.
    Hillengass, J.
    Glasmacher, A.
    Goldschmidt, H.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (06) : 431 - 440
  • [10] Thalidomide in multiple myeloma
    Rajkumar, SV
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 11 - 16
12345